[1]
“Study of the Efficacy and Safety of Stereotactic Radiation Therapy in Combination with Trastuzumab Emtansine Immunoconjugate in Patients with HER-2-positive Oligometastatic Breast Cancer. Interim Results”, Вопр. онкол., vol. 71, no. 3, p. OF-2347, Jun. 2025, doi: 10.37469/0507-3758-2025-71-3-OF-2347.